Overview
Denosumab is an injectable medication that reduces bone loss.

Indications
Osteoporosis or high fracture risk.

How it helps
Inhibits bone resorption pathways.

Implementation
Injection every six months under medical supervision.

Expected timeline
Improves bone density over months to years.

When to seek care
Do not miss doses; stopping abruptly increases fracture risk.